Editorial: Genetic Pleiotropy in Complex Traits and Diseases
Qian Xu,Can Yang,Yu-Fang Pei
DOI: https://doi.org/10.3389/fgene.2022.897383
IF: 3.7
2022-01-01
Frontiers in Genetics
Abstract:Genetic pleiotropy, the phenomenon of a single gene or a single genetic variant influencing multiple phenotypes, appears to be pervasive in human genome. Thousands of genome-wide association studies (GWASes) have identified hundreds of thousands of genetic variants associated with hundreds of complex traits or diseases. Watanabe et al. (2019) systematically analyzed more than 4,000 publicly available GWASes, indicating the presence of widespread pleiotropy at the levels of genes (63%) and SNPs (31%). Identification of pleiotropic effects may help to explain the observations for shared heritability and comorbidity among multiple complex traits and shed light on the underlying biological mechanisms for those traits. However, progress in the identification and understanding of genetic pleiotropic effects remains limited. Indeed, the associations of genetic loci withmultiple traits observed inGWAS studies are cross-phenotype associations, which are distinguished from pleiotropic effects. Solovieff et al. (2013) described three broad categories of pleiotropy in the context of complex traits: biological pleiotropy, mediated pleiotropy and spurious pleiotropy. In recent years, with the increasing publicly availability of GWAS summary statistics, a number of statistical methods have been developed to evaluate the genetic overlap between multiple traits and diseases. Existing multi-trait methods can be broadly divided into multivariate methods and univariate methods (Hackinger and Zeggini, 2017). Univariate methods combine single-trait GWAS summary statistics to detect pleiotropic genetic variants. On the contrary, multivariate methods analyze all of the interesting traits in a unified model, which often require that individuallevel genotype and phenotype data for all traits analyzed (Hackinger and Zeggini, 2017). Although existing statistical methods are available for detecting pleiotropic effects, it is still very challenging for systematic characterization of pleiotropy. New methodologies are highly demanding for interpreting the results of cross-phenotypes associations. In the research topic on “Genetic Pleiotropy in Complex Traits and Diseases,” eight original studies are collected. It mainly focuses on the field of novel methodology development, identification of novel pleiotropic loci and the pathogenic mechanism of gene polymorphism in complex diseases. Specifically, three studies focus on the development of novel methodology for detecting multitraits associations based on GWAS summary data. Liu et al. presented powerful procedures to jointly analyze multiple traits based on GWAS summary statistics. They first adopted the generalized BerkJones (GBJ) test and the generalized higher criticism (GHC) test to analyze multiple traits and then combined the p-values of GBJ, GHC and the existing MinP (the minimum of the p-values) test by the aggregated Cauchy association test, namely omnibus (OMNI) test. The proposed tests can well control the type I error rate and the OMNI test is robust to the signal directions, the correlation structures and the degrees of sparsity. Replication plays a key role in evaluating the credibility of pleiotropic effects. Ning et al. evaluated four methods for replicating multi-trait associations and Edited and reviewed by: Simon Charles Heath, Center for Genomic Regulation (CRG), Spain